Squarepoint’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-484
Closed -$17.3K 5180
2024
Q4
$17.3K Sell
484
-2,781
-85% -$144K ﹤0.01% 4944
2024
Q3
$154K Sell
3,265
-6,847
-68% -$302K ﹤0.01% 3775
2024
Q2
$508K Buy
+10,112
New +$731K ﹤0.01% 3069
2024
Q1
Sell
-547
Closed -$31.7K 4449
2023
Q4
$31.7K Buy
+547
New +$22K ﹤0.01% 3888
2023
Q3
Sell
-16,729
Closed -$1.38M 4102
2023
Q2
$1.38M Buy
16,729
+16,240
+3,321% +$2.38M 0.01% 1929
2023
Q1
$50.3K Sell
489
-3,413
-87% -$479K ﹤0.01% 3057
2022
Q4
$572K Buy
3,902
+3,287
+534% +$556K ﹤0.01% 2194
2022
Q3
$104K Sell
615
-8,440
-93% -$1.37M ﹤0.01% 2788
2022
Q2
$1.05M Sell
9,055
-10,505
-54% -$988K 0.01% 1575
2022
Q1
$1.95M Buy
19,560
+16,893
+633% +$1.97M 0.01% 1174
2021
Q4
$415K Buy
+2,667
New +$519K ﹤0.01% 2268
2021
Q3
Sell
-1,700
Closed -$577K 3241
2021
Q2
$577K Sell
1,700
-517
-23% -$196K ﹤0.01% 2023
2021
Q1
$897K Buy
2,217
+410
+23% +$199K 0.01% 1597
2020
Q4
$1.2M Buy
1,807
+1,019
+129% +$567K 0.01% 1202
2020
Q3
$367K Sell
788
-250
-24% -$126K 0.01% 1650
2020
Q2
$607K Buy
1,038
+554
+114% +$189K 0.01% 1199
2020
Q1
$71K Buy
+484
New +$84.6K ﹤0.01% 1691

Other funds holding MRSN